Optical diagnostic imaging and therapy for thyroid cancer. (15th December 2022)

• Record Type: Journal Article
• Authors: Shao, Chengying; Li, Zhenfang; Zhang, Chengchi; Zhang, Wanchen; He, Ru; Xu, Jiajie; Cai, Yu
• Is Part Of: Materials today bio. Volume 17(2023)
• Publication Date: 2022-12-15
• Subjects: Optical imaging -- Phototherapy -- Thyroid cancer -- Multimodal therapy -- Optical imaging-guided surgery; 131I-BSA@CuS 131I-labeled BSA-modified CuS nanoparticles -- 5-ALA 5-Aminolevulinic acid -- ASIR age-standardized rates of cancer incidence -- ATC anaplastic thyroid carcinoma -- AuNCs@BSA-I innovative iodinated gold nanoclusters -- Au@MSNs photo-triggered Gold nanodots capped mesoporous silica nanoparticles -- BRAF V-Raf murine sarcoma viral oncogene homolog B -- CBDCA Carboplatin -- CDFI color doppler flow imaging ultrasound -- ECDT enhanced chemodynamical therapy -- CLND central compartmentalized node dissection -- CPDA-131I NPs the 131I-radiolabeled cerebroid polydopamine nano-particles -- CT Computed Tomography -- DOT Diffuse Optical Tomography -- DTC differentiated thyroid cancer -- EGF epidermal growth factor -- EGFR epidermal growth factor receptor -- ESMO European Society of Medical Oncology -- FDA U.S. Food and Drug Administration -- FI fluorescence imaging -- FNAB fine-needle aspiration biopsy -- FNAs fine needle aspirations -- FTC follicular thyroid carcinoma -- GC germinal center -- HAOA Hyaluronic Acid and Oleic Acid -- HYP hypericin -- ICG indocyanine green -- IJV internal jugular vein -- IR825@B-PPNs Polymeric NPs with bevacizumab and IR825 conjugated on the surface -- L-A PTA laparoscopic photothermal ablation -- MDR multidrug resistance -- mETE microscopic extrathyroidal extension -- MTC medullary thyroid carcinoma -- NIR near-infrared -- NIRF near-infrared fluorescence -- NIR-FI near-infrared fluorescence imaging -- NIR-PIT near-infrared photoimmunotherapy -- NMRI Nuclear Magnetic Resonance Imaging -- OCT Optical Coherence Tomography -- OI optical imaging -- OS overall survival -- PAI Photoacoustic Imaging -- Pd-MOF porphyrin–palladium metal–organic framework -- PDT photodynamic therapy -- PET Positron Emission Tomography -- PGs parathyroid glands -- PLP porphyrin-HDL nanoparticle -- PTA photothermal reagents -- PTC papillary thyroid carcinoma -- PTT photothermal therapy -- RIT radioactive iodine therapy -- ROS reactive oxygen species -- SEC Selenocysteine -- SiRNA interfering RNA -- SV subclavian vein -- TC thyroid cancer -- TD Thoracic Duct -- TF tissue factor; Materials science -- Periodicals; Biomedical engineering -- Periodicals; Biomedical materials -- Periodicals; 620.1
• DOI: 10.1016/j.mtbio.2022.100441
• Languages: English
• ISSNs: 2590-0064

Abstract

Abstract: Thyroid cancer, as one of the most common endocrine cancers, has seen a surge in incidence in recent years. This is most likely due to the lack of specificity and accuracy of its traditional diagnostic modalities, leading to the overdiagnosis of thyroid nodules. Although there are several treatment options available, they are limited to surgery and 131 I radiation therapy that come with significant side effects and hence cannot meet the treatment needs of anaplastic thyroid carcinoma with very high malignancy. Optical imaging that utilizes optical absorption, refraction and scattering properties, not only observes the structure and function of cells, tissues, organs, or even the whole organism to assist in diagnosis, but can also be used to perform optical therapy to achieve targeted non-invasive and precise treatment of thyroid cancer. These applications of screening, diagnosis, and treatment, lend to optical imaging's promising potential within the realm of thyroid cancer surgical navigation. Over the past decade, research on optical imaging in the diagnosis and treatment of thyroid cancer has been growing year by year, but no comprehensive review on this topic has been published. Here, we review key advances in the application of optical imaging in the diagnosis and treatment of thyroid cancer and discuss the challenges and potential for clinical translation of this technology. Graphical abstract: Image 1